array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "Oppenheimer Holdings Inc." ["slug"]=> string(33) "d9d67-us-oppenheimer-holdings-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/a99751a9-e5ba-47be-b7b8-15581b246381" ["description"]=> string(1060) "Oppenheimer & Co. Inc. is a leading national investment boutique with over a century of tradition. Oppenheimer’s culture of providing innovative, customized solutions to our clients sets us apart from our competitors. Oppenheimer is proud of its reputation as a Firm that helps individuals, families, corporate executives, foundations and endowments, charities, pension plans businesses, and institutions. We occupy a unique position in the industry, thanks to the dedication, expertise, and creativity of our people. Oppenheimer Financial Advisors draw on the extensive resources and expertise of nearly 1,900 other professionals, including those in Equity Research, Capital Markets, and Investment Banking. Oppenheimer Asset Management Inc., Oppenheimer Life Agency Ltd., Oppenheimer Trust Company of Delaware and Oppenheimer & Co. Inc. are wholly owned subsidiaries of Oppenheimer Holdings Inc., an integrated financial holding company. Oppenheimer is a registered broker-dealer and investment advisory firm. Securities are offered through Oppenheimer. " ["address_street"]=> string(17) "85 Broad St FL 22" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1881-02-13" ["website_domain"]=> string(8) "opco.com" ["website_url"]=> string(20) "https://www.opco.com" ["industry_codes"]=> array(3) { [0]=> string(50) "Security Brokers, Dealers, and Flotation Companies" [1]=> string(33) "Offices of Bank Holding Companies" [2]=> string(39) "Management Investment Offices, Open-End" } ["employee_count"]=> int(7) ["article_count"]=> int(321) } ["articles"]=> array(3) { [0]=> array(7) { ["title_en"]=> string(128) "Oppenheimer Expands Public Finance Department and Demonstrates Leadership in the Space with the Addition of an MSRB Board Member" ["snippet_en"]=> string(160) "/PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a unit of Oppenheimer Holdings (NYSE: OPY), today announced an expansion of the Firm's Public Finance..." ["url"]=> string(184) "https://www.prnewswire.com/news-releases/oppenheimer-expands-public-finance-department-and-demonstrates-leadership-in-the-space-with-the-addition-of-an-msrb-board-member-300506669.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e104f7d4-b9a5-419d-91eb-46182a0c3ff4" ["source"]=> string(14) "prnewswire.com" ["publication_date"]=> string(10) "2017-08-21" ["categories"]=> array(3) { [0]=> string(18) "Expansion & Growth" [1]=> string(12) "Board Change" [2]=> string(25) "Leadership and Governance" } } [1]=> array(7) { ["title_en"]=> string(103) "Oppenheimer & Co. Inc. Expands Its Healthcare Investment Banking by Adding a Leading Life Sciences Team" ["snippet_en"]=> string(162) "/PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") a unit of Oppenheimer Holdings (NYSE: OPY), announced the hiring of a new Life Sciences team to join the..." ["url"]=> string(156) "https://www.prnewswire.com/news-releases/oppenheimer--co-inc-expands-its-healthcare-investment-banking-by-adding-a-leading-life-sciences-team-300426088.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ce324b5a-2e9d-4f52-9b67-9ad26ec331cb" ["source"]=> string(14) "prnewswire.com" ["publication_date"]=> string(10) "2017-03-20" ["categories"]=> array(1) { [0]=> string(18) "Expansion & Growth" } } [2]=> array(7) { ["title_en"]=> string(40) "OvaScience closes $53.8m financing round" ["snippet_en"]=> string(217) "OvaScience (NSDQ:OVAS) said today it closed a $53.8 million funding round as it looks to expand its Augment treatment in Japan and Canada and support pre-commercial activities for its OvaPrime and OvaTure treatments." ["url"]=> string(67) "https://www.massdevice.com/ovascience-closes-53-8m-financing-round/" ["image_url"]=> NULL ["source"]=> string(14) "massdevice.com" ["publication_date"]=> string(10) "2016-06-01" ["categories"]=> array(2) { [0]=> string(18) "Expansion & Growth" [1]=> string(7) "Funding" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(55) } [1]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(37) } [2]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(27) } [3]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(16) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(16) } [5]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(12) } [6]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(10) } [7]=> array(2) { ["name"]=> string(25) "Leadership and Governance" ["count"]=> int(7) } [8]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(5) } [9]=> array(2) { ["name"]=> string(15) "Corporate Fines" ["count"]=> int(4) } [10]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(3) } [11]=> array(2) { ["name"]=> string(5) "Fraud" ["count"]=> int(3) } [12]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(3) } [13]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(3) } [14]=> array(2) { ["name"]=> string(5) "Debts" ["count"]=> int(2) } [15]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(2) } [16]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(2) } [17]=> array(2) { ["name"]=> string(17) "Commodity Pricing" ["count"]=> int(2) } [18]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(2) } [19]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(2) } [20]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(1) } [22]=> array(2) { ["name"]=> string(12) "Restatements" ["count"]=> int(1) } [23]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(1) } [24]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(1) } [25]=> array(2) { ["name"]=> string(12) "Slash Prices" ["count"]=> int(1) } [26]=> array(2) { ["name"]=> string(5) "SPACs" ["count"]=> int(1) } [27]=> array(2) { ["name"]=> string(10) "Tax Havens" ["count"]=> int(1) } [28]=> array(2) { ["name"]=> string(8) "Accident" ["count"]=> int(1) } [29]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(1) } } } d9d67-us-oppenheimer-holdings-inc

Oppenheimer Holdings Inc.

Location

New York

Founded

1881-02-13

Website

https://www.opco.com

Articles

321 Articles

Category

Security Brokers, Dealers, and Flotation Companies

Offices of Bank Holding Companies

Management Investment Offices, Open-End

Description

Oppenheimer & Co. Inc. is a leading national investment boutique with over a century of tradition. Oppenheimer’s culture of providing innovative, customized solutions to our clients sets us apart from our competitors. Oppenheimer is proud of its reputation as a Firm that helps individuals, families, corporate executives, foundations and endowments, charities, pension plans businesses, and institutions. We occupy a unique position in the industry, thanks to the dedication, expertise, and creativity of our people. Oppenheimer Financial Advisors draw on the extensive resources and expertise of nearly 1,900 other professionals, including those in Equity Research, Capital Markets, and Investment Banking. Oppenheimer Asset Management Inc., Oppenheimer Life Agency Ltd., Oppenheimer Trust Company of Delaware and Oppenheimer & Co. Inc. are wholly owned subsidiaries of Oppenheimer Holdings Inc., an integrated financial holding company. Oppenheimer is a registered broker-dealer and investment advisory firm. Securities are offered through Oppenheimer.

Articles

Oppenheimer Expands Public Finance Department and Demonstrates Leadership in the Space with the Addition of an MSRB Board Member

2017-08-21 (prnewswire.com)

Oppenheimer Expands Public Finance Department and Demonstrates Leadership in the Space with the Addition of an MSRB Board Member

/PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a unit of Oppenheimer Holdings (NYSE: OPY), today announced an expansion of the Firm's Public Finance...

Read more
Oppenheimer & Co. Inc. Expands Its Healthcare Investment Banking by Adding a Leading Life Sciences Team

2017-03-20 (prnewswire.com)

Oppenheimer & Co. Inc. Expands Its Healthcare Investment Banking by Adding a Leading Life Sciences Team

/PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") a unit of Oppenheimer Holdings (NYSE: OPY), announced the hiring of a new Life Sciences team to join the...

Read more
OvaScience closes $53.8m financing round

2016-06-01 (massdevice.com)

OvaScience closes $53.8m financing round

OvaScience (NSDQ:OVAS) said today it closed a $53.8 million funding round as it looks to expand its Augment treatment in Japan and Canada and support pre-commercial activities for its OvaPrime and OvaTure treatments.

Read more

Newsletter subscription